WHITEHAWK THERAPEUTICS, INC. Capital Expenditures
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Capital Expenditures of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- WHITEHAWK THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $552.00K, a 66.63% decline from fiscal 2024.
- WHITEHAWK THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $1.65M, a 58.36% decline from fiscal 2023.
- WHITEHAWK THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $3.97M, a 794.59% increase from fiscal 2022.
- WHITEHAWK THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $444.00K, a 865.22% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | $1.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $1.00K derived: sum of 3 quarters · filed 2026-08-06 | $552.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.00K derived: sum of 2 quarters · filed 2026-08-06 | $552.00K 10-Q · filed 2025-11-06 | $738.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $552.00K 10-Q · filed 2026-08-06 | $738.00K derived: sum of 3 quarters · filed 2026-08-06 | $926.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $551.00K 10-Q · filed 2026-05-07 | $737.00K derived: sum of 2 quarters · filed 2026-05-07 | $925.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.47M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $186.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $374.00K derived: sum of 2 quarters · filed 2026-03-12 | $915.00K derived: sum of 3 quarters · filed 2026-03-12 | $1.65M 10-K · filed 2026-03-12 |
| 2024-09-30 | $188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $729.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.47M 10-Q · filed 2025-11-06 | $2.28M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $541.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.28M 10-Q · filed 2025-08-07 | $2.10M derived: sum of 3 quarters · filed 2025-08-07 | $3.19M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $739.00K 10-Q · filed 2025-05-08 | $1.55M derived: sum of 2 quarters · filed 2025-05-08 | $2.65M derived: sum of 3 quarters · filed 2025-05-08 | $3.34M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $816.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $1.91M derived: sum of 2 quarters · filed 2025-03-28 | $2.60M derived: sum of 3 quarters · filed 2025-03-28 | $3.97M 10-K · filed 2025-03-28 |
| 2023-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.79M derived: sum of 2 quarters · filed 2024-11-06 | $3.16M 10-Q · filed 2024-11-06 | $3.23M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $689.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $2.06M 10-Q · filed 2024-08-07 | $2.14M derived: sum of 3 quarters · filed 2024-08-07 | $2.24M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $1.37M 10-Q · filed 2024-05-08 | $1.45M derived: sum of 2 quarters · filed 2024-05-08 | $1.55M derived: sum of 3 quarters · filed 2024-05-08 | $1.79M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $180.00K derived: sum of 2 quarters · filed 2024-03-13 | $421.00K derived: sum of 3 quarters · filed 2024-03-13 | $444.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | $102.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $343.00K derived: sum of 2 quarters · filed 2023-11-08 | $366.00K 10-Q · filed 2023-11-08 | $412.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $241.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $264.00K 10-Q · filed 2023-08-09 | $310.00K derived: sum of 3 quarters · filed 2023-08-09 | $310.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $23.00K 10-Q · filed 2023-05-10 | $69.00K derived: sum of 2 quarters · filed 2023-05-10 | $69.00K derived: sum of 3 quarters · filed 2023-05-10 | |
| 2021-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $46.00K derived: sum of 2 quarters · filed 2023-03-29 | $46.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $6.83K derived: sum of 2 quarters · filed 2021-03-11 | $19.02K 10-K · filed 2021-03-11 | |
| 2020-09-30 | $6.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $19.02K 10-Q · filed 2020-11-10 | ||
| 2020-06-30 | $12.20K 10-Q · filed 2021-08-11 | |||
| 2019-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $4.28K derived: sum of 2 quarters · filed 2021-03-11 | $123.67K derived: sum of 3 quarters · filed 2021-03-11 | $236.95K 10-K · filed 2021-03-11 |
| 2019-09-30 | $4.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $123.67K derived: sum of 2 quarters · filed 2020-11-10 | $236.95K 10-Q · filed 2020-11-10 | $245.49K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $119.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $232.67K 10-Q · filed 2020-08-12 | $241.20K derived: sum of 3 quarters · filed 2020-08-12 | $262.09K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $113.28K 10-Q · filed 2020-05-07 | $121.81K derived: sum of 2 quarters · filed 2020-05-07 | $142.70K derived: sum of 3 quarters · filed 2020-05-07 | $142.70K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $8.53K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $29.41K derived: sum of 2 quarters · filed 2020-03-16 | $29.41K derived: sum of 3 quarters · filed 2020-03-16 | $37.91K 10-K · filed 2020-03-16 |
| 2018-09-30 | $20.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $20.88K derived: sum of 2 quarters · filed 2019-11-07 | $29.38K 10-Q · filed 2019-11-07 | $31.73K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $8.50K 10-Q · filed 2019-08-08 | $10.85K derived: sum of 3 quarters · filed 2019-08-08 | $10.85K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $8.50K 10-Q · filed 2019-05-09 | $10.85K derived: sum of 2 quarters · filed 2019-05-09 | $10.85K derived: sum of 3 quarters · filed 2019-05-09 | $15.19K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $2.35K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $2.35K derived: sum of 2 quarters · filed 2019-03-07 | $6.69K derived: sum of 3 quarters · filed 2019-03-07 | $8.90K 10-K · filed 2019-03-07 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $4.34K derived: sum of 2 quarters · filed 2018-11-07 | $6.55K 10-Q · filed 2018-11-07 | $6.55K derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | $4.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $6.55K 10-Q · filed 2018-08-14 | $6.55K derived: sum of 3 quarters · filed 2018-08-14 | $6.55K derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $2.21K 10-Q · filed 2018-05-15 | $2.21K derived: sum of 2 quarters · filed 2018-05-15 | $2.21K derived: sum of 3 quarters · filed 2018-05-15 | $5.06K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $2.85K derived: sum of 3 quarters · filed 2018-03-15 | $113.30K 10-K · filed 2018-03-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $2.85K derived: sum of 2 quarters · filed 2017-11-13 | $113.30K 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $2.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $113.30K 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | $110.45K 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |